Caricamento...
Effects of denosumab on bone density, mass and strength in women with postmenopausal osteoporosis
Denosumab is a human monoclonal antibody which specifically blocks receptor activator of nuclear factor κB ligand and is a very potent antiresorptive drug. Its efficacy in reducing the risk of vertebral, hip and nonskeletal fracture has been proven in a large prospective, randomized multicenter stud...
Salvato in:
| Pubblicato in: | Ther Adv Musculoskelet Dis |
|---|---|
| Autore principale: | |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
SAGE Publications
2015
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4426099/ https://ncbi.nlm.nih.gov/pubmed/26029270 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1759720X15579189 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|